688356 键凯科技
已收盘 11-22 15:00:01
资讯
新帖
简况
键凯科技(688356)11月22日主力资金净卖出240.99万元
证券之星 · 08:23
键凯科技(688356)11月22日主力资金净卖出240.99万元
11月22日键凯科技跌6.18%,大成丰享回报混合A基金重仓该股
证券之星 · 11-22 16:19
11月22日键凯科技跌6.18%,大成丰享回报混合A基金重仓该股
键凯科技跌5% 近半年1券商买入
智选洞察 · 11-22 13:21
键凯科技跌5% 近半年1券商买入
键凯科技:2023年公司国外药品端客户收入为1487万元,百分比差异为尾差导致,再次
证券之星 · 11-15
键凯科技:2023年公司国外药品端客户收入为1487万元,百分比差异为尾差导致,再次
11月15日键凯科技跌5.12%,大成丰享回报混合A基金重仓该股
证券之星 · 11-15
11月15日键凯科技跌5.12%,大成丰享回报混合A基金重仓该股
键凯科技大跌5.01% 2家券商给予买入建议
智选洞察 · 11-14
键凯科技大跌5.01% 2家券商给予买入建议
键凯科技:36000股限售股将于11月19日上市流通
证券 · 11-13
键凯科技:36000股限售股将于11月19日上市流通
键凯科技11月13日主力资金流入773万元 连续3日加仓
市场透视 · 11-13
键凯科技11月13日主力资金流入773万元 连续3日加仓
键凯科技:伊立替康项目立项较早,当时尚不具备开展中美双报条件
每日经济新闻 · 11-12
键凯科技:伊立替康项目立项较早,当时尚不具备开展中美双报条件
键凯科技:注射用透明质酸钠复合溶液项目数据统计仍在进行
证券之星 · 11-12
键凯科技:注射用透明质酸钠复合溶液项目数据统计仍在进行
键凯科技(688356.SH):JK1201I治疗合并有脑转移的三阴性乳腺癌II期临床研究完成首例受试者入组
智通财经 · 11-12
键凯科技(688356.SH):JK1201I治疗合并有脑转移的三阴性乳腺癌II期临床研究完成首例受试者入组
键凯科技创1个月新高 中国医疗器械进出口额上涨
智选洞察 · 11-11
键凯科技创1个月新高 中国医疗器械进出口额上涨
键凯科技11月06日主力资金流出164万元 连续7日减仓
市场透视 · 11-06
键凯科技11月06日主力资金流出164万元 连续7日减仓
键凯科技:注射用透明质酸钠复合溶液项目的具体进展情况以公司后续相关公告为准
证券之星 · 11-04
键凯科技:注射用透明质酸钠复合溶液项目的具体进展情况以公司后续相关公告为准
键凯科技(688356)2024年三季报简析:净利润减67.5%,三费占比上升明显
证券之星 · 11-01
键凯科技(688356)2024年三季报简析:净利润减67.5%,三费占比上升明显
键凯科技(688356)9月30日股东户数0.52万户,较上期增加3.29%
证券之星 · 10-31
键凯科技(688356)9月30日股东户数0.52万户,较上期增加3.29%
键凯科技大跌5.12% 获主力净流出616万元
智选洞察 · 10-29
键凯科技大跌5.12% 获主力净流出616万元
10月18日键凯科技涨6.84%,北信瑞丰健康生活基金重仓该股
证券之星 · 10-18
10月18日键凯科技涨6.84%,北信瑞丰健康生活基金重仓该股
键凯科技大幅上涨 获3家券商买入建议
智选洞察 · 10-18
键凯科技大幅上涨 获3家券商买入建议
键凯科技: 伊立替康项目脑胶质瘤适应症二期临床仍在进展中,相关进展情况以公司后续相关公告为准
证券之星 · 10-11
键凯科技: 伊立替康项目脑胶质瘤适应症二期临床仍在进展中,相关进展情况以公司后续相关公告为准
公司概况
公司名称:
北京键凯科技股份有限公司
所属行业:
化学原料和化学制品制造业
上市日期:
2020-08-26
主营业务:
北京键凯科技股份有限公司主要从事医用药用聚乙二醇及其活性衍生物的研发、生产和销售。公司主要产品为医用药用聚乙二醇及其活性衍生物。公司在聚乙二醇及其活性衍生物研发、生产、医药领域应用等技术领域处于国内领先地位,是国内外为数不多能进行高纯度和低分散度的医用药用聚乙二醇及活性衍生物工业化生产的公司之一,填补了国内长期缺乏规模化生产高质量的医用药用聚乙二醇及其衍生物这一空白,是全球市场的主要新兴参与者。
发行价格:
41.18
{"stockData":{"symbol":"688356","market":"SH","secType":"STK","nameCN":"键凯科技","latestPrice":56.01,"timestamp":1732258801000,"preClose":59.7,"halted":0,"volume":677635,"delay":0,"floatShares":60650700,"shares":60650700,"eps":0.7902,"marketStatus":"已收盘","marketStatusCode":5,"change":-3.69,"latestTime":"11-22 15:00:01","open":59.7,"high":59.7,"low":55.76,"amount":38940400,"amplitude":0.066,"askPrice":56.03,"askSize":10,"bidPrice":56.01,"bidSize":13,"shortable":0,"etf":0,"ttmEps":0.7902,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":59.7,"symbolType":"stock_kcb","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":65.67,"lowLimit":53.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":60650700,"pbRate":2.68,"roa":"--","roe":"2.55%","epsLYR":1.92,"committee":0.408451,"marketValue":3397000000,"floatMarketCap":3397000000,"peRate":70.88079,"changeRate":-0.0618,"turnoverRate":0.0112,"status":1,"nextConnectDate":"根据港交所公布的数据,今日已停止北向交易,下一个交易日为北京时间 2024-11-25。","afterMarket":{"amount":0,"volume":0,"close":56.01,"buyVolume":0,"sellVolume":0,"time":1732260839464,"indexStatus":"已收盘 11-22 15:30:00","preClose":59.7}},"requestUrl":"/m/hq/s/688356/wiki","defaultTab":"wiki","newsList":[{"id":"2485241286","title":"键凯科技(688356)11月22日主力资金净卖出240.99万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2485241286","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485241286?lang=zh_cn&edition=full","pubTime":"2024-11-23 08:23","pubTimestamp":1732321402,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年11月22日收盘,键凯科技报收于56.01元,下跌6.18%,换手率1.12%,成交量6776.0手,成交额3894.04万元。近5日资金流向一览见下表:键凯科技融资融券信息显示,融资方面,当日融资买入811.27万元,融资偿还572.41万元,融资净买入238.86万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112300006482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2485233625","title":"11月22日键凯科技跌6.18%,大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2485233625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485233625?lang=zh_cn&edition=full","pubTime":"2024-11-22 16:19","pubTimestamp":1732263599,"startTime":"0","endTime":"0","summary":"证券之星消息,11月22日键凯科技跌6.18%,收盘报56.01元,换手率1.12%,成交量6776.0手,成交额3894.04万元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为大成丰享回报混合A。大成丰享回报混合A目前规模为0.38亿元,最新净值1.0981,较上一交易日上涨0.06%,近一年上涨6.93%。大成丰享回报混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112200025845.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2485400117","title":"键凯科技跌5% 近半年1券商买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2485400117","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485400117?lang=zh_cn&edition=full","pubTime":"2024-11-22 13:21","pubTimestamp":1732252861,"startTime":"0","endTime":"0","summary":"11月22日,键凯科技股价大幅下跌,截至13点21分,键凯科技下跌5.11%,报56.65元/股,成交2240万元,换手率0.64%。此外,数据统计显示,近半年内1家券商给予买入建议。资金动向截止发稿,键凯科技获得主力净流出59万元,其中超大单流出82万元,大单流入23万元。最新财报显示,今年三季报,键凯科技实现营业收入1.86亿元,同比减少23.97%,净利润为3,265.37万元,同比减少67.50%,基本每股收益为0.54元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122132120a24d05d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122132120a24d05d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2483470393","title":"键凯科技:2023年公司国外药品端客户收入为1487万元,百分比差异为尾差导致,再次","url":"https://stock-news.laohu8.com/highlight/detail?id=2483470393","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483470393?lang=zh_cn&edition=full","pubTime":"2024-11-15 18:00","pubTimestamp":1731664823,"startTime":"0","endTime":"0","summary":"证券之星消息,键凯科技11月15日在投资者关系平台上答复投资者关心的问题。据2023年报问询函回复公告披露(第4页),2023年公司国际药品端客户收入占比10.2%,2023年国外销售年收入141,841,516.6元,按10.2%比例计算药品端客户收入应为1447万,为何与第11页披露的1487万存在出入?2023年公司国外药品端客户收入为1487万元,百分比差异为尾差导致,再次感谢您对键凯科技的关注。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500031586.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2483348022","title":"11月15日键凯科技跌5.12%,大成丰享回报混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2483348022","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483348022?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:10","pubTimestamp":1731658221,"startTime":"0","endTime":"0","summary":"证券之星消息,11月15日键凯科技跌5.12%,收盘报60.65元,换手率1.16%,成交量7014.0手,成交额4367.6万元。根据2024基金Q3季报公募基金重仓股数据,重仓该股的公募基金共1家,其中持有数量最多的公募基金为大成丰享回报混合A。大成丰享回报混合A目前规模为0.38亿元,最新净值1.0966,较上一交易日下跌0.25%,近一年上涨6.83%。大成丰享回报混合A的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111500025117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2483810065","title":"键凯科技大跌5.01% 2家券商给予买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2483810065","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483810065?lang=zh_cn&edition=full","pubTime":"2024-11-14 14:51","pubTimestamp":1731567091,"startTime":"0","endTime":"0","summary":"11月14日,键凯科技股价大幅下跌,截至14点51分,键凯科技下跌5.01%,报63.50元/股,成交4254万元,换手率1.07%,振幅6.13%。此外,数据统计显示,近半年内2家券商给予买入建议。资金动向截止发稿,键凯科技获得主力净流出464万元,其中超大单流出2万元,大单流出460万元。最新财报显示,今年三季报,键凯科技实现营业收入1.86亿元,同比减少23.97%,净利润为3,265.37万元,同比减少67.50%,基本每股收益为0.54元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114145141abbfefa8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241114145141abbfefa8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2483070988","title":"键凯科技:36000股限售股将于11月19日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2483070988","media":"证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483070988?lang=zh_cn&edition=full","pubTime":"2024-11-13 18:37","pubTimestamp":1731494220,"startTime":"0","endTime":"0","summary":"证券日报网讯11月13日晚间,键凯科技发布关于2021年限制性股票激励计划预留授予部分第二个归属期归属结果暨股份上市公告称,本次股票上市类型为公司股权激励股份;股票认购方式为网下,本次股票上市流通总数为36,000股。本次股票上市流通日期为2024年11月19日。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-11-13/doc-incvxpff1172931.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-11-13/doc-incvxpff1172931.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2483593025","title":"键凯科技11月13日主力资金流入773万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2483593025","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483593025?lang=zh_cn&edition=full","pubTime":"2024-11-13 15:20","pubTimestamp":1731482419,"startTime":"0","endTime":"0","summary":"11月13日, 键凯科技股价涨2.33%,报收66.85元,成交金额6965万元,换手率1.73%,振幅5.48%,量比1.09。键凯科技今日主力资金净流入773万元,连续3日净流入,上一交易日主力净流入367万元,今日环比增加110.63%。近一年数据显示,该股主力连续3日净流入后,次日上涨概率为70.00%,平均涨幅为2.81%。该股近5个交易日上涨15.78%,主力资金累计净流入1515万元;近20日主力资金累计净流出2422万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113153219abbc7534&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113153219abbc7534&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2482770102","title":"键凯科技:伊立替康项目立项较早,当时尚不具备开展中美双报条件","url":"https://stock-news.laohu8.com/highlight/detail?id=2482770102","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482770102?lang=zh_cn&edition=full","pubTime":"2024-11-12 19:47","pubTimestamp":1731412069,"startTime":"0","endTime":"0","summary":"每经AI快讯,有投资者在投资者互动平台提问:请问赵总,公司是出于何种考虑,没有将聚乙二醇伊立替康在美国申请临床试验?公司的经验方针不是实现国内国际双循环吗,公司为何没有遵循这一方针?键凯科技(688356.SH)11月12日在投资者互动平台表示,伊立替康项目立项较早,当时尚不具备开展中美双报条件。目前公司将优先推进伊立替康项目的三期临床。公司一直遵循国内国际双循环的经营方针,2024年前三季度,国际销售收入约占公司主营业务收入的60%。(记者 毕陆名)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112194841a2306196&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241112194841a2306196&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2482720574","title":"键凯科技:注射用透明质酸钠复合溶液项目数据统计仍在进行","url":"https://stock-news.laohu8.com/highlight/detail?id=2482720574","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482720574?lang=zh_cn&edition=full","pubTime":"2024-11-12 17:00","pubTimestamp":1731402050,"startTime":"0","endTime":"0","summary":"证券之星消息,键凯科技11月12日在投资者关系平台上答复投资者关心的问题。注射用透明质酸钠复合溶液项目数据统计仍在进行。目前公司将优先推进伊立替康项目的三期临床。后续,公司将综合考虑多方面因素,根据相关政策及公司规定,统筹考虑高管薪酬事宜。再次感谢您对键凯科技的关注。以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024111200028384.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2482372785","title":"键凯科技(688356.SH):JK1201I治疗合并有脑转移的三阴性乳腺癌II期临床研究完成首例受试者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=2482372785","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482372785?lang=zh_cn&edition=full","pubTime":"2024-11-12 16:49","pubTimestamp":1731401389,"startTime":"0","endTime":"0","summary":"智通财经APP讯,键凯科技 发布公告,公司自主研发的注射用聚乙二醇伊立替康用于治疗伴脑转移的三阴性乳腺癌的II期临床试验“JK1201I治疗合并有脑转移的三阴性乳腺癌II期临床研究”已于近日完成首例受试者入组。在前期的非临床试验中,JK1201I表现出了较市售盐酸伊立替康更优的疗效和安全性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209797.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2482922584","title":"键凯科技创1个月新高 中国医疗器械进出口额上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2482922584","media":"智选洞察","labels":["Business Data"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482922584?lang=zh_cn&edition=full","pubTime":"2024-11-11 13:13","pubTimestamp":1731302032,"startTime":"0","endTime":"0","summary":"11月11日,键凯科技股价大幅上涨,截至13点13分,键凯科技上涨5.19%,报63.63元/股,创近1个月新高,成交4111万元,换手率1.10%,振幅6.73%。数据显示,前三季度,我国医疗器械进出口贸易额621.9亿美元,同比上涨0.1%,其中出口353.4亿美元,同比增长了4.4%。资金动向截止发稿,键凯科技获得主力净流出261万元,其中超大单流出338万元,大单流入78万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131746a22b4558&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111131746a22b4558&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Business Data","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159883","688356","BK0229"],"gpt_icon":0},{"id":"2481640370","title":"键凯科技11月06日主力资金流出164万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481640370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481640370?lang=zh_cn&edition=full","pubTime":"2024-11-06 15:19","pubTimestamp":1730877545,"startTime":"0","endTime":"0","summary":"11月06日, 键凯科技股价跌0.62%,报收57.74元,成交金额3342万元,换手率0.94%,振幅4.10%,量比0.76。键凯科技今日主力资金净流出164万元,连续7日净流出,上一交易日主力净流出106万元,今日环比增加54.72%。该股近5个交易日下跌0.28%,主力资金累计净流出2014万元,其中2个交易日为股价上涨时净流出;近20日主力资金累计净流出5517万元,其中净流出天数为15日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106153707aba530ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106153707aba530ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2480379616","title":"键凯科技:注射用透明质酸钠复合溶液项目的具体进展情况以公司后续相关公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2480379616","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480379616?lang=zh_cn&edition=full","pubTime":"2024-11-04 17:00","pubTimestamp":1730710811,"startTime":"0","endTime":"0","summary":"注射用透明质酸钠复合溶液项目的具体进展情况以公司后续相关公告为准。未来如有该计划,将按照有关监管法规的要求及时履行信息披露义务,具体请以公司公告为准。聚乙二醇交联透明质酸钠项目仍在根据发补材料清单补充材料,公司相关信息请以指定信息披露媒体的公告内容为准,再次感谢您对键凯科技的关注。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110400021913.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2480096977","title":"键凯科技(688356)2024年三季报简析:净利润减67.5%,三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2480096977","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480096977?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:27","pubTimestamp":1730413626,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期键凯科技发布2024年三季报。截至本报告期末,公司营业总收入1.86亿元,同比下降23.97%,归母净利润3265.37万元,同比下降67.5%。按单季度数据看,第三季度营业总收入5713.97万元,同比下降21.56%,第三季度归母净利润470.9万元,同比下降85.38%。本报告期键凯科技三费占比上升明显,财务费用、销售费用和管理费用总和占总营收同比增幅达46.63%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100005984.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356"],"gpt_icon":0},{"id":"2479774623","title":"键凯科技(688356)9月30日股东户数0.52万户,较上期增加3.29%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479774623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479774623?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:12","pubTimestamp":1730365942,"startTime":"0","endTime":"0","summary":"证券之星消息,近日键凯科技披露,截至2024年9月30日公司股东户数为5180.0户,较6月30日增加165.0户,增幅为3.29%。在化学制药行业个股中,键凯科技股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.1万户。从股价来看,2024年6月30日至2024年9月30日,键凯科技区间涨幅为8.88%,在此期间股东户数增加165.0户,增幅为3.29%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100033852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2479812443","title":"键凯科技大跌5.12% 获主力净流出616万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479812443","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479812443?lang=zh_cn&edition=full","pubTime":"2024-10-29 13:20","pubTimestamp":1730179210,"startTime":"0","endTime":"0","summary":"10月29日,键凯科技股价大幅下跌,截至13点20分,键凯科技下跌5.12%,报58.88元/股,失守60元整数关口,成交4348万元,换手率1.19%,振幅6.40%。资金动向截止发稿,键凯科技获得主力净流出616万元,其中超大单流出196万元,大单流出419万元。最新财报显示,今年中报,键凯科技实现营业收入1.29亿元,同比减少24.99%,净利润为2,794.48万元,同比减少59.06%,基本每股收益为0.46元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029132025a1f41793&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029132025a1f41793&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2476799472","title":"10月18日键凯科技涨6.84%,北信瑞丰健康生活基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2476799472","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476799472?lang=zh_cn&edition=full","pubTime":"2024-10-18 16:21","pubTimestamp":1729239675,"startTime":"0","endTime":"0","summary":"证券之星消息,10月18日键凯科技涨6.84%,收盘报58.77元,换手率1.57%,成交量9499.0手,成交额5415.7万元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共2家,其中持有数量最多的公募基金为北信瑞丰健康生活。北信瑞丰健康生活目前规模为0.88亿元,最新净值0.913,较上一交易日下跌0.76%,近一年下跌30.31%。北信瑞丰健康生活的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101800025942.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688356"],"gpt_icon":0},{"id":"2476440608","title":"键凯科技大幅上涨 获3家券商买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2476440608","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476440608?lang=zh_cn&edition=full","pubTime":"2024-10-18 13:19","pubTimestamp":1729228752,"startTime":"0","endTime":"0","summary":"10月18日,键凯科技股价大幅上涨,截至13点19分,键凯科技上涨5.07%,报57.80元/股,成交2295万元,换手率0.69%,振幅8.36%。此外,数据统计显示,近半年内3家券商给予买入建议。资金动向截止发稿,键凯科技获得主力净流出367万元,其中超大单流出125万元,大单流出240万元。最新财报显示,今年中报,键凯科技实现营业收入1.29亿元,同比减少24.99%,净利润为2,794.48万元,同比减少59.06%,基本每股收益为0.46元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018133334ab6b0a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241018133334ab6b0a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688356","BK0229"],"gpt_icon":0},{"id":"2474066659","title":"键凯科技:\n伊立替康项目脑胶质瘤适应症二期临床仍在进展中,相关进展情况以公司后续相关公告为准","url":"https://stock-news.laohu8.com/highlight/detail?id=2474066659","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474066659?lang=zh_cn&edition=full","pubTime":"2024-10-11 18:01","pubTimestamp":1728640896,"startTime":"0","endTime":"0","summary":"证券之星消息,键凯科技10月11日在投资者关系平台上答复投资者关心的问题。伊立替康项目脑胶质瘤适应症二期临床仍在进展中,相关进展情况以公司后续相关公告为准。再次感谢您对键凯科技的关注。聚乙二醇交联透明质酸钠项目仍在根据发补材料清单补充材料;注射用复合透明质酸钠溶液项目临床试验截至目前随访期已经结束,进入数据统计阶段,预计在2024年第四季度完成临床实验。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100028617.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","688356"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2020-08-26","address":"北京市海淀区西小口路66号中关村东升科技园·北领地C-1楼3层306、308、310、311(东升地区)","stockEarnings":[{"period":"1week","weight":-0.0765},{"period":"1month","weight":-0.0765},{"period":"3month","weight":0.1489},{"period":"6month","weight":-0.1632},{"period":"1year","weight":-0.528},{"period":"ytd","weight":-0.4689}],"companyName":"北京键凯科技股份有限公司","boardCode":"AI0026","perCapita":"11708股","boardName":"化学原料和化学制品制造业","registeredCapital":"6065万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 北京键凯科技股份有限公司主要从事医用药用聚乙二醇及其活性衍生物的研发、生产和销售。公司主要产品为医用药用聚乙二醇及其活性衍生物。公司在聚乙二醇及其活性衍生物研发、生产、医药领域应用等技术领域处于国内领先地位,是国内外为数不多能进行高纯度和低分散度的医用药用聚乙二醇及活性衍生物工业化生产的公司之一,填补了国内长期缺乏规模化生产高质量的医用药用聚乙二醇及其衍生物这一空白,是全球市场的主要新兴参与者。","serverTime":1732372135782,"listedPrice":41.18,"stockholders":"5180人(较上一季度增加3.29%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"键凯科技(688356)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供键凯科技(688356)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"键凯科技,688356,键凯科技股票,键凯科技股票老虎,键凯科技股票老虎国际,键凯科技行情,键凯科技股票行情,键凯科技股价,键凯科技股市,键凯科技股票价格,键凯科技股票交易,键凯科技股票购买,键凯科技股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"键凯科技(688356)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供键凯科技(688356)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}